Merck's oral HIV treatment non-inferior to Gilead's Biktarvy in late-stage trial

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

Eswatini is the first African country to get twice-yearly HIV prevention shot

Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...
TruthoutOpinion

Key HIV Programs in the US Are in Danger — and the Impact Will Be Devastating

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
News Medical on MSN

Medicaid Expansion Increases Access to HIV Prevention Medication for High-Risk Populations

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...
AllAfrica on MSN

HIV Kits and Medicine Shortages Loom, Amupanda Warns

Lawmaker and Affirmative Repositioning (AR) leader Job Amupanda has warned that HIV testing kits along with other essential medications may soon run out completely at public hospitals if urgent action ...
The Lancet

Seema Sahay—linking behavioural science and HIV research

Today, Seema Sahay is Head of Division of Social Behavioural Research at the Indian Council of Medical Research, National Institute of Translational Virology & AIDS Research (NARI), Pune, India.